Latest news

2 months ago

Ibogaine and Noribogaine: Mechanisms and Therapeutic Potential as Addiction Medicines

2 months ago

Exploring the Future of VR and Digital Therapeutics

2 months ago

The Unparalleled Power of Ibogaine in Addiction Recovery With Tom Feegel, CEO of Beond

2 months ago

Breaking the Cycle of Addiction with Ibogaine

2 months ago

Ibogaine Receives Serious Media Attention

2 months ago

Powerful Psychedelic Gains Renewed Attention as a Treatment for Opioid Addiction

2 months ago

Psychedelics Today Ep. 448: Deborah C. Mash, Ph.D. – Ibogaine, Noribogaine, and the Challenges of Federal Drug Policy

2 months ago

Opium Addiction Market expected to rise – BioCorRx Inc, Delpor Inc, DemeRx Inc, Alar Pharmaceuticals, expected to drive market

2 months ago

Advocates of using psychedelic drug ibogaine to treat addiction say its risks to the heart can be mitigated in a controlled study

2 months ago

Kentucky’s $42 million allocation for psychedelics research for opioid addiction